Viewpoint CSO leads the DOE Pb-212 Users Meeting at SNMMI
August 23, 2019
June 22nd, 2019 – Anaheim, California, Chief Science Officer Michael Schultz, PhD led the Department of Energy Pb-212 User Meeting at the Society of Nuclear Medicine and Molecular Imaging 2019 Annual Meeting. The meeting was held in Anaheim, CA in late June. Dr. Schultz has led this event at the SNMMI Annual meeting for that last three years. The event is a forum for all people in the radiopharmaceutical community (physicians, scientists, technologists) come together to share success and challenges in the introduction of alpha-particle radionuclide therapy for cancer using Pb-212.